Search research articles
Contact Us
Filters
Showing results (201-210 of 207) with videos related to
Page
of 21
Sort By:
You have reached the last page of results.
This site can display upto 207 results.
Cancer Cell
|
June 25, 2021
Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity
Ariella B Hanker, Benjamin P Brown, Jens Meiler, et al.
Cancer Discovery
|
February 10, 2019
Correction: An Acquired <i>HER2</i> <sup>T798I</sup> Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer
Ariella B Hanker, Monica Red Brewer, Jonathan H Sheehan, et al.
Cancer Discovery
|
March 10, 2017
An Acquired <i>HER2</i><sup>T798I</sup> Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer
Ariella B Hanker, Monica Red Brewer, Jonathan H Sheehan, et al.
Molecular Genetics & Genomic Medicine
|
April 18, 2019
IgG4-related disease: Association with a rare gene variant expressed in cytotoxic T cells
John H Newman, Aaron Shaver, Jonathan H Sheehan, et al.
Cancer Discovery
|
April 23, 2016
EGFR Fusions as Novel Therapeutic Targets in Lung Cancer
Kartik Konduri, Jean-Nicolas Gallant, Young Kwang Chae, et al.
Biochemistry
|
March 11, 2021
Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design
Clara T Schoeder, Samuel Schmitz, Jared Adolf-Bryfogle, et al.
Molecular Genetics & Genomic Medicine
|
December 17, 2025
Phenotypic Variability and Paternal Inheritance of a CHD8 Variant Causing Intellectual Developmental Disorder With Autism and Macrocephaly Confirmed by Epigenetic and Structural Analyses
Yutaka Furuta, Kimberly M Ezell, Rizwan Hamid, et al.
Page
of 21
Search research articles
Search
Showing results (201-210 of 207) with videos related to
Sort By:
Page
of 21
You have reached the last page of results.
This site can display upto 207 results.
Cancer Cell
|
June 25, 2021
Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity
Ariella B Hanker, Benjamin P Brown, Jens Meiler, et al.
Cancer Discovery
|
February 10, 2019
Correction: An Acquired <i>HER2</i> <sup>T798I</sup> Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer
Ariella B Hanker, Monica Red Brewer, Jonathan H Sheehan, et al.
Cancer Discovery
|
March 10, 2017
An Acquired <i>HER2</i><sup>T798I</sup> Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer
Ariella B Hanker, Monica Red Brewer, Jonathan H Sheehan, et al.
Molecular Genetics & Genomic Medicine
|
April 18, 2019
IgG4-related disease: Association with a rare gene variant expressed in cytotoxic T cells
John H Newman, Aaron Shaver, Jonathan H Sheehan, et al.
Cancer Discovery
|
April 23, 2016
EGFR Fusions as Novel Therapeutic Targets in Lung Cancer
Kartik Konduri, Jean-Nicolas Gallant, Young Kwang Chae, et al.
Biochemistry
|
March 11, 2021
Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design
Clara T Schoeder, Samuel Schmitz, Jared Adolf-Bryfogle, et al.
Molecular Genetics & Genomic Medicine
|
December 17, 2025
Phenotypic Variability and Paternal Inheritance of a CHD8 Variant Causing Intellectual Developmental Disorder With Autism and Macrocephaly Confirmed by Epigenetic and Structural Analyses
Yutaka Furuta, Kimberly M Ezell, Rizwan Hamid, et al.
Page
of 21